Search All Resources
Buprenorphine Prescribing in a Pandemic | April 16, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #buprenorphine #medication access
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews best practices for buprenorphine prescribing during COVID-19 and the changing regulations around prescribing. She also shares a sample model for increasing access to buprenorphine.
Date added: 04/16/20
Trauma Informed Care and COVID-19 | April 2, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #covid-19 #trauma #trauma-informed care
Dr. Danica Love Brown, Behavioral Health Manager at the Northwest Portland Area Indian Health Board, describes the principles of trauma informed care and shares some tips for mental health wellness during quarantine.
Date added: 04/2/20
COVID-19 | March 18, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #covid clinical updates #covid-19
Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, and Whitney Essex, Family Nurse Practitioner for the Cherokee Nation Health Service, provide an overview of COVID-19, including the epidemiology, clinical manifestations, testing for COVID-19, and how ...
Date added: 03/18/20
Microdose Buprenorphine Inductions | March 5, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #buprenorphine #microdosing #outpatient microdosing
Dr. Jennifer Hartley, a Family Medicine Practitioner at Portland Urgent Care, defines microdosing, provides an overview of microdosing protocols for buprenorphine, reviews several case studies, and explains how to implement outpatient buprenorphine microdosing.
Date added: 03/5/20
Introduction to Harm Reduction | February 20, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #harm reduction #lummi #syringe services
Jessica Rienstra, Hepatitis C Project Coordinator at Lummi Tribal Health Center, shares an overview of harm reduction principles and the benefits of harm reduction for both patients and providers. She also shares some history and provides an overview of the ...
Date added: 02/20/20
Trickster Tails | February 6, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #indigenous knowledge #opioids #OUD #traditions
Dr. Danica Love Brown, Behavioral Health Manager at the Northwest Portland Area Indian Health Board, demonstrates how traditional indigenous knowledge and stories can aid in overcoming trauma related to opioid addiction.
Date added: 02/6/20
Medications for Opioid Use Disorder: Who Should Get What When? | January 16, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #buprenorphine #methadone #naltrexone #opioid substitution therapy #opioids #OUD
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares methadone, buprenorphine, and extended release naltrexone in terms of efficacy on a stable dose, induction, retention, and systems-level constraints.
Date added: 01/16/20
Maternal Substance Use Disorders and Infant Withdrawal Syndromes in Hospital Deliveries Among American Indians/Alaska Natives | December 19, 2019
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #fetal alcohol spectrum disorder #infant withdrawal #maternal child health #maternal substance use disorders #neonatal abstinence syndrome
In this presentation, Dr. Chiao-Wen Lan, Dr. Tom Weiser, and Sujata Joshi from the Northwest Portland Area Indian Health Board, discuss how prenatal exposure to substances can negatively affect fetal development. They also look at the effects on fetal development ...
Date added: 12/19/19
Microdose Buprenorphine Inductions | December 5, 2019
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #buprenorphine #microdosing #outpatient microdosing
Dr. Jennifer Hartley, a Family Medicine Practitioner at Portland Urgent Care, defines microdosing, provides an overview of microdosing protocols for buprenorphine, reviews several case studies, and explains how to implement outpatient buprenorphine microdosing.
Date added: 12/5/19
Let’s Talk About PrEP | November 21, 2019
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #HIV prevention #pre-exposure prophylaxis #prep
Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Service, and Whitney Essex, Family Nurse Practitioner for Cherokee Nation Health Service, explain PrEP, the process in which an HIV-negative person who is at very high risk for acquiring ...
Date added: 11/21/19